Back to Search Start Over

The human neuroprotective placental protein composition suppressing tinnitus and restoring auditory brainstem response in a rodent model of sodium salicylate-induced ototoxicity.

Authors :
Farhadi M
Gorji A
Mirsalehi M
Müller M
Poletaev AB
Mahboudi F
Asadpour A
Ebrahimi M
Beiranvand M
Khaftari MD
Akbarnejad Z
Mahmoudian S
Source :
Heliyon [Heliyon] 2023 Aug 11; Vol. 9 (8), pp. e19052. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).
Publication Year :
2023

Abstract

The effect of neuroprotective placental protein composition (NPPC) on the suppression of tinnitus and the restoration of the auditory brainstem response (ABR) characteristics was explored in tinnitus-induced rats. The animals were placed into two groups: (1) the study group, rats received sodium salicylate (SS) at the dose of 200 mg/kg twice a day for two weeks, and then 0.4 mg of the NPPC per day, between the 14th and 28th days, (2) the placebo group, rats received saline for two weeks, and then the NPPC alone between the 14th and 28th days. The gap pre-pulse inhibition of the acoustic startle (GPIAS), the pre-pulse inhibition (PPI), and the ABR assessments were performed on animals in both groups three times (baseline, day 14, and 28). The GPIAS value declined after 14 consecutive days of the SS injection, while NPPC treatment augmented the GPIAS score in the study group on the 28th day. The PPI outcomes revealed no significant changes, indicating hearing preservation after the SS and NPPC administrations. Moreover, some changes in ABR characteristics were observed following SS injection, including (1) higher ABR thresholds, (2) lowered waves I and II amplitudes at the frequencies of 6, 12, and 24 kHz and wave III at the 12 kHz, (3) elevated amplitude ratios, and (4) prolongation in brainstem transmission time (BTT). All the mentioned variables returned to their normal values after applying the NPPC. The NPPC use could exert positive therapeutic effects on the tinnitus-induced rats and improve their ABR parameters.<br />Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Mohammad Farhadi reports financial support was provided by 10.13039/501100003968Iran National Science Foundation. Dr. Saeid Mahmoudian reports financial support and administrative support were provided by ENT and Head and Neck Research Center, The Five Senses Health Institute, 10.13039/100012021Iran University of Medical Sciences.<br /> (© 2023 Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
2405-8440
Volume :
9
Issue :
8
Database :
MEDLINE
Journal :
Heliyon
Publication Type :
Academic Journal
Accession number :
37636471
Full Text :
https://doi.org/10.1016/j.heliyon.2023.e19052